
Overview
Status
Active
Registry date
2001-09-11
Share capital
50,000.00 PLN
Registered address
ul. Jana I Jędrzeja Śniadeckich 17, 00-654 Warszawa, Poland
Website
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2025 – the filing deadline has passed. 4 of 6 financial statements were filed late (the longest delay 407 days for 2023). 5 of 6 audited by a statutory auditor.
- 2025not filed
- 202410/12/2025
- 202326/08/2025
- 202214/06/2024
- 202110/08/2023
- 202030/09/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.
Sector · Wholesale and retail trade; repair of motor vehicles including motorcycles4,540 / 42,241
Top 11%
Voivodeship · Mazowieckie7,958 / 142,033
Top 5.6%
Country · Poland27,171 / 495,860
Top 5.5%
Results vs industry
Revenue
This companyUSD 9.11mMedianUSD 1.07mAverageUSD 22.38m
Net profit
This companyUSD 216.75kMedianUSD 37.89kAverageUSD 879.28k
Operating costs
This companyUSD 8.77mMedianUSD 929.75kAverageUSD 21.06m
Assets
This companyUSD 5.37mMedianUSD 609.81kAverageUSD 11.84m
Industry
Offer
- Subcutaneous immunotherapy
- Sublingual immunotherapy
- Allergy diagnostics
- Allergen extracts
- Clinical trials
Website technology
- Website
- WordPress
- Analytics and marketing
- Google Tag Manager
Authorized Representatives
Arnaud Van Oers – Management Board Member
Marek Jarosław Jąkalski – President of the Management Board
Manner of representation
Two members of the management board acting jointly are authorized to make declarations of will and sign on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Hal Allergy Holding B.v. | 500 | $13,506.21 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2003-12-31.
37 1880 0009 0000 0011 0243 5000
Debt
No entries in the National Debtors Register (KRZ).
Public aid
4 public aid cases recorded, with a total value of $563,954.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 19, 2020 | Other crisis aid | $13,038$13,038 | Prezydent Miasta Stołecznego Warszawy | |
| Jun 18, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $539.1K$539,089 | Polski Fundusz Rozwoju S.A. | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $7,259$7,259 | Prezes Zakładu Ubezpieczeń Społecznych |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Panawitsp. z o.o. | $10,791,432.08 | panawit.pl | ||
| Carnamedicasp. z o.o. | $10,629,942.92 | carnamedica.com | ||
| Boironsp. z o.o. | $9,932,832.64 | boiron.pl | ||
| Creator-Commsp. z o.o. | $8,811,210.35 | creator-comm.pl | ||
| MassmedicaS.A. | $8,216,274.00 | massmedica.com | ||
| Dentsply Sirona Europe GmbhBranch (foreign co.) | $8,136,922.37 | dentsplysirona.com | ||
| Wellmedica Hfsp. z o.o. | $8,037,044.71 | wellmedica.pl | ||
| Bionesissp. z o.o. | $7,788,948.87 | bionesis.pl | ||
| Techdow Pharma Polandsp. z o.o. | $7,550,624.85 | techdow.pl | ||
| Abooksp. z o.o. | $7,496,765.35 | abook.com.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-04-08 | Address change (Rumiana 65, 02-956, Warszawa → Ul. Jana I Jędrzeja Śniadeckich 17, 00-654, Warszawa) | |
| 2005-05-10 | Address change (Kochanowskiego 73/1, 51-602, Wrocław → Rumiana 65, 02-956, Warszawa) | |
| 2005-05-10 | Share capital increase (20,000.00 PLN → 50,000.00 PLN) | |
| 2001-09-11 | Entered in the register |
FAQ
The main business activity of HAL Allergy focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on September 11, 2001.
The headquarters is located at: ul. Jana I Jędrzeja Śniadeckich 17, 00-654 Warszawa.
The management board includes Marek Jarosław Jąkalski (President of the Management Board).
The share capital of the company is PLN 50,000 (approx. $13,506).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
In 2024, the company generated total revenue of $9,112,910.
Yes, in 2024 the company was profitable, achieving a net profit of $216,745.
The largest operating cost category falls under cost of goods and materials sold. This category amounted to $7,267,602 in 2024, representing 83% of all operating expenses.
Last updated: 2026-10-07